Sagaliam Acquisition Corp. announced that it has amended the executed non-binding term sheet for the purchase of Biogenysis Inc. ("BGEN") and Virogentics Inc. ("VIRO"), operating subsidiaries of Enzolytics Inc. amending the combined purchase price to $450,000,000. Additionally, the company announce that Ronnie Richardson, Krystine Miller, and Travis Richardson are joining Board of Directors.
Sagaliam Acquisition Corp.
Equities
SAGA
US78661R1068
Investment Holding Companies
1st Jan change | Capi. | |
---|---|---|
+58.06% | 4.89B | |
+98.02% | 1.23B | |
+2.71% | 988M | |
+16.68% | 763M | |
+2.11% | 666M | |
+2.33% | 621M | |
-.--% | 600M | |
+10.56% | 537M | |
-.--% | 500M |